Leal, A.F.; Benincore-Flórez, E.; Solano-Galarza, D.; Garzón Jaramillo, R.G.; Echeverri-Peña, O.Y.; Suarez, D.A.; Alméciga-DÃaz, C.J.; Espejo-Mojica, A.J.
GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies. Int. J. Mol. Sci. 2020, 21, 6213.
https://doi.org/10.3390/ijms21176213
AMA Style
Leal AF, Benincore-Flórez E, Solano-Galarza D, Garzón Jaramillo RG, Echeverri-Peña OY, Suarez DA, Alméciga-DÃaz CJ, Espejo-Mojica AJ.
GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies. International Journal of Molecular Sciences. 2020; 21(17):6213.
https://doi.org/10.3390/ijms21176213
Chicago/Turabian Style
Leal, Andrés Felipe, Eliana Benincore-Flórez, Daniela Solano-Galarza, Rafael Guillermo Garzón Jaramillo, Olga Yaneth Echeverri-Peña, Diego A. Suarez, Carlos Javier Alméciga-DÃaz, and Angela Johana Espejo-Mojica.
2020. "GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies" International Journal of Molecular Sciences 21, no. 17: 6213.
https://doi.org/10.3390/ijms21176213
APA Style
Leal, A. F., Benincore-Flórez, E., Solano-Galarza, D., Garzón Jaramillo, R. G., Echeverri-Peña, O. Y., Suarez, D. A., Alméciga-DÃaz, C. J., & Espejo-Mojica, A. J.
(2020). GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies. International Journal of Molecular Sciences, 21(17), 6213.
https://doi.org/10.3390/ijms21176213
